DOI QR코드

DOI QR Code

Successful Treatment of Neonatal Pylorospasm with Intravenous Atropine

  • Kim, Hyeong Jung (Division of Neonatology, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Shin, Jeong Eun (Division of Neonatology, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Han, Jung Ho (Division of Neonatology, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Lim, Joo Hee (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Lee, Soon Min (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Park, Min Soo (Division of Neonatology, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Park, Kook In (Division of Neonatology, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Namgung, Ran (Division of Neonatology, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Eun, Ho Seon (Division of Neonatology, Severance Children's Hospital, Yonsei University College of Medicine)
  • Received : 2018.09.16
  • Accepted : 2018.11.22
  • Published : 2019.02.28

Abstract

Pylorospasm is a cause of delayed gastric emptying in young infants. As in patients with hypertrophic pyloric stenosis, most pylorospasm patients present with projectile vomiting. However, unlike that in case of hypertrophic pyloric stenosis, no persistent pyloric stenotic lesions are present. As such, follow-up using serial gastrointestinal fluoroscopy or ultrasonography can be helpful in diagnosing patients with clinical signs of gastroparesis. Most cases can be treated conservatively, but some patients require pharmacologic treatment. Antispasmodics have been proposed as a treatment for pylorospasm, but their use in neonates and infants has rarely been reported. Herein, we present a case of pylorospasm diagnosed in the neonatal period and successfully treated with intravenous atropine.

Keywords

References

  1. Gilet AG, Dunkin J, Cohen HL. Pylorospasm (simulating hypertrophic pyloric stenosis) with secondary gastroesophageal reflux. Ultrasound Q 2008;24:93-6. https://doi.org/10.1097/RUQ.0b013e31817c6113
  2. Cohen HL, Zinn HL, Haller JO, Homel PJ, Stoane JM. Ultrasonography of pylorospasm: findings may simulate hypertrophic pyloric stenosis. J Ultrasound Med 1998;17:705-11. https://doi.org/10.7863/jum.1998.17.11.705
  3. Cohen HL, Blumer SL, Zucconi WB. The sonographic doubletrack sign: not pathognomonic for hypertrophic pyloric stenosis; can be seen in pylorospasm. J Ultrasound Med 2004;23:641-6. https://doi.org/10.7863/jum.2004.23.5.641
  4. Islam S. Gastroparesis in children. Curr Opin Pediatr 2015;27:377-82. https://doi.org/10.1097/MOP.0000000000000216
  5. Tillman EM, Smetana KS, Bantu L, Buckley MG. Pharmacologic treatment for pediatric gastroparesis: a review of the literature. J Pediatr Pharmacol Ther 2016;21:120-32. https://doi.org/10.5863/1551-6776-21.2.120
  6. Heidelbaugh JJ. Gastrointestinal diseases: a multidisciplinary approach. Philadelphia: Elsevier Health Science, 2015:309.
  7. Hilas O. Management of gastroparesis. US Pharm 2011;36:HS15-8.
  8. Lauriti G, Cascini V, Chiesa PL, Pierro A, Zani A. Atropine treatment for hypertrophic pyloric stenosis: a systematic review and meta-analysis. Eur J Pediatr Surg 2018;28:393-9. https://doi.org/10.1055/s-0037-1604116
  9. Wu SF, Lin HY, Huang FK, Chen AC, Su BH, Li CI, et al. Efficacy of medical treatment for infantile hypertrophic pyloric stenosis: a meta-analysis. Pediatr Neonatol 2016;57:515-21. https://doi.org/10.1016/j.pedneo.2016.02.005